BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 15814992)

  • 1. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
    Tan GL; Peterson EM
    J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
    Linares MJ; Charriel G; Solís F; Casal M
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
    Lee SC; Lo HJ; Fung CP; Lee N; See LC
    J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species.
    Pfaller MA; Boyken L; Messer SA; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2004 Nov; 42(11):4977-9. PubMed ID: 15528683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disk diffusion method for fluconazole susceptibility testing of Candida spp. isolates].
    Rodero L; Córdoba S; Vivot W; Campo M; Corfield P; Olguín C; Cuirolo A; Soria M; Guelfand L; Canteros CE; Davel G;
    Rev Argent Microbiol; 2006; 38(3):155-63. PubMed ID: 17152217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro fluconazole susceptibility of 1565 clinical isolates of Candida species evaluated by the disk diffusion method performed using NCCLS M44-A guidelines.
    Testore GP; Dori L; Buonomini AR; Schito GC; Soro O; Fortina G; Andreoni S; Carlone N; Tullio V; Andreoni M
    Diagn Microbiol Infect Dis; 2004 Nov; 50(3):187-92. PubMed ID: 15541604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disk diffusion testing using Candida sp. colonies taken directly from CHROMagar Candida medium may decrease time required to obtain results.
    Klevay M; Ebinger A; Diekema D; Messer S; Hollis R; Pfaller M
    J Clin Microbiol; 2005 Jul; 43(7):3497-9. PubMed ID: 16000489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation and utility of the E-test and Neo-Sensitabs methods in studying fluconazole yeast susceptibility].
    Cantón E; Pemán J; Sastre M; Valentín A; Bosch M; Espinel-Ingroff A
    Rev Esp Quimioter; 2006 Sep; 19(3):267-74. PubMed ID: 17099795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.
    Kronvall G; Karlsson I
    J Clin Microbiol; 2001 Apr; 39(4):1422-8. PubMed ID: 11283066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
    Durán MT; Velasco D; Canle D; Moure R; Villanueva R
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of different susceptibility testing methods and media on determination of the relevant fluconazole minimum inhibitory concentrations for heavy trailing Candida isolates with low-high phenotype.
    Alp S; Sancak B; Hascelik G; Arikan S
    Mycoses; 2010 Nov; 53(6):475-80. PubMed ID: 19563491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
    Fleck R; Dietz A; Hof H
    J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid identification of fluconazole resistance using Chromagar Candida.
    Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
    Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
    Quindós G; Sánchez-Vargas LO; Villar-Vidal M; Eraso E; Alkorta M; Hernández-Almaraz JL
    Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Candida species to fluconazole assayed by a disk diffusion method with automated reading versus a microdilution method.
    Finquelievich JL; Iovannitti CA; Mujica MT; Relloso S; Carnovale S; de Elías Costa MR; Jewtuchowicz V; Espinel-Ingroff A
    Rev Argent Microbiol; 2003; 35(4):214-8. PubMed ID: 14976874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp.
    Sims CR; Paetznick VL; Rodriguez JR; Chen E; Ostrosky-Zeichner L
    J Clin Microbiol; 2006 Jun; 44(6):2105-8. PubMed ID: 16757605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct fluconazole susceptibility testing of positive Candida blood cultures by flow cytometry.
    Rudensky B; Broide E; Berko N; Wiener-Well Y; Yinnon AM; Raveh D
    Mycoses; 2008 May; 51(3):200-4. PubMed ID: 18399900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
    Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
    Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.